← Leaderboards
Berkley E Gryder
Case Western Reserve University
$1,730,521
Attributed
$1,730,521
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $606.9K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,730,521 · 2
By mechanism
R01$1,205,236 · 1
K22$525,285 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Laura E. Nagy$35,655,521
- Helen C Miranda$3,600,204
- Helen Karen Salz$9,180,651
- Nancy L Oleinick$4,281,905
- Sanjay Gupta$6,255,407
Others in their field
Other Emerging Leaders on “Genome-Wide”
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,306,947
- Badri N Vardarajan · University Of Miami School Of Medicine$20,206,265
- Brian William Kunkle · University Of Miami School Of Medicine$13,466,231
- Leonard Freedmand · Leidos Biomedical Research, Inc.$11,639,100
- Jacqueline K White · Jackson Laboratory$11,525,170
Research focus
Genome-WideGenetic TranscriptionEnhancersGenesClinically RelevantGenetic CorepressorChip-SeqDeprivationGene Expression RegulationGene ExpressionChromatinAndrogen ReceptorAdvanced Prostate CancerAndrogen SensitiveAddictionCell LineAgonistAutomobile DrivingAdultEpigenetic ProcessAndrogen Deprivation TherapyCellsAcetylationHomeostasis
Grant awards (5)
Mechanisms of Androgen Receptor Inverse Agonists in Advanced Prostate Cancer$598,367
R01 · FY2025 · CA · contact PI
Mechanisms of Androgen Receptor Inverse Agonists in Advanced Prostate Cancer$606,869
R01 · FY2024 · CA · contact PI
Chemical Epigenomic Strategies to Overcome Metastatic Castration Resistant Prostate Cancer$175,095
K22 · FY2023 · CA · contact PI
Chemical Epigenomic Strategies to Overcome Metastatic Castration Resistant Prostate Cancer$175,095
K22 · FY2022 · CA · contact PI
Chemical Epigenomic Strategies to Overcome Metastatic Castration Resistant Prostate Cancer$175,095
K22 · FY2021 · CA · contact PI